Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
Phase 2
Completed
- Conditions
- Acute Myelogenous LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia
- Interventions
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00334074
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Combined Modality Treatment for Patients With Stage IV Melanoma
Phase 1
Completed
- Conditions
- Malignant Melanoma Stage IV
- Interventions
- Biological: DC Vaccine and Cyclophosphamide
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2013-06-13
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 41
- Registration Number
- NCT00313235
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Improving Diabetes Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Other: Medicare Claims FeedbackOther: Medical Record ReviewOther: Diabetes Resource Nurse
- First Posted Date
- 2005-11-28
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 1891
- Registration Number
- NCT00258674
- Locations
- 🇺🇸
Baylor Health Care System Institute for Health Care Research and Improvement, Dallas, Texas, United States
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
Not Applicable
Completed
- Conditions
- Heart DiseasesCardiovascular DiseasesCoronary Disease
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 250
- Registration Number
- NCT00224809
- Locations
- 🇺🇸
Baylor Research Institute, Dallas, Texas, United States
Pancreatic Islet Cell Transplantation
Phase 1
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Biological: Islet cell transplantation
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 4
- Registration Number
- NCT00214786
- Locations
- 🇺🇸
Baylor Regional Transplant Institute - Baylor University Medical Center, Dallas, Texas, United States
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Phase 4
Completed
- Conditions
- Hepatitis CEnd Stage Liver Disease
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 312
- Registration Number
- NCT00163657
- Locations
- 🇺🇸
Baylor Regional Transplant Institute - Baylor University Medical Center, Dallas, Texas, United States
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
Phase 1
Completed
- Conditions
- MelanomaNeoplasm Metastasis
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00125749
- Locations
- 🇺🇸
Mary Crowley Medical Research Center: Baylor University Medical Center, Dallas, Texas, United States
Dosing Study of Replagal in Patients With Fabry Disease
- First Posted Date
- 2003-09-08
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 13
- Registration Number
- NCT00068107
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States